The public record · 119th Congress

Biosimilar Inspection Modernization Act of 2025

The Congressional Research Service has not published a summary of this measure.

Other titles

the names this measure carries besides the one at the top of this page, each with the record's own label for it. The collection includes titles given to parts of a bill as well as to the whole.

A bill to improve the inspections of drug establishments engaged in the manufacture, preparation, propagation, or processing of biosimilar biological products conducted by the Food and Drug Administration, and for other purposes.Official Title as Introduced

Biosimilar Inspection Modernization Act of 2025Short Title(s) as Introduced

Legislative history

S. 3510·Senate·Bill·Health

Sen. Ted Budd(Republican-North Carolina)·

Dec 16, 2025

SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Documents

Everything Congress printed about this measure. A bill is reprinted each time it changes, the Congressional Research Service summarizes each version, and the committee that reports a bill files its own written account of it.

Bill text

Dec 16, 2025As introduced in the Senate